Then a whitepaper and now a peer-reviewed article in Diabetes Care, ADA's journal. First, there was a poster at ADA last June. The evidence is clear. Medicare's program to save money on test diabetes strips cost more in hospital care than it saved and increased mortality. Learn more ACT NOW Previously on YDMV: Getting Off the Harm Merrygoround Throw the Red Flag. Bidding Strips in No Touchdown Of Test Strips, Bidding, and Harm

For the past year we have been providing you with a monthly whitepaper on SGLT-2 inhibitors ([link] and for the past 7 weeks we have been discussing the emerging role that the kidney plays in glucose homeostasis.

Update to post below: Amy Tenderich (Diabetes Mine) has posted a couple updates on this issue, including a whitepaper released by Roche and an interview with Ellen Ullman, mother to a son with type 1 and the only patient advocate at the FDA’s meeting.

FDA has a whitepaper out on drug development and it has some background on diabetes (T1 and T2) and how they go about drug approval. Here is the preface of what they say about diabetes and a link to the section of the whitepaper on diabetes: our understanding of disease causation and progression is sufficient to permit our use of certain tools such as surrogate endpoints. Are you a policy geek?

However, a peer-reviewed journal article recently published in Diabetes Care (fee for full article access) shows otherwise ( press release (3/2016)), ( press release (12/2015, includes a free link to the whitepaper the published article is based on)).

Before Indiana, back in the Shores of Michigan, there was Lindas - an open-all-day-and-night place where stories could be shared, souls could be searched and written ramblings often emerged on whitepaper napkins. The Diabetics Corner Booth A daily brew of Coffee and Conversation, Poetry and Prose about the world we live in - through the eyes of a newspaper journalist Living with Type 1 Diabetes for a quarter-century. Read All About It. MORE >>

Before Indiana, back in the Shores of Michigan, there was Lindas - an open-all-day-and-night place where stories could be shared, souls could be searched and written ramblings often emerged on whitepaper napkins. The Diabetics Corner Booth A daily brew of Coffee and Conversation, Poetry and Prose about the world we live in - through the eyes of a newspaper journalist Living with Type 1 Diabetes for a quarter-century. Read All About It. MORE >>

Before Indiana, back in the Shores of Michigan, there was Lindas - an open-all-day-and-night place where stories could be shared, souls could be searched and written ramblings often emerged on whitepaper napkins. The Diabetics Corner Booth A daily brew of Coffee and Conversation, Poetry and Prose about the world we live in - through the eyes of a newspaper journalist Living with Type 1 Diabetes for a quarter-century. Read All About It. MORE >>

Before Indiana, back in the Shores of Michigan, there was Lindas - an open-all-day-and-night place where stories could be shared, souls could be searched and written ramblings often emerged on whitepaper napkins. The Diabetics Corner Booth A daily brew of Coffee and Conversation, Poetry and Prose about the world we live in - through the eyes of a newspaper journalist Living with Type 1 Diabetes for a quarter-century. Read All About It. MORE >>

FOREVER LATER , She had me all bagged up in a giant handled whitepaper bag. They don't like me at the pharmacy and really, I don't blame them. To be honest, I don't like them either. I think the main reason I am so bothersome to them is that I hold up lines with my big order. Three times insulin. Three times test strips. Three times glucagon. USUALLY what happens is I put in my order and the pharmacist is smart enough to see that all the boys use the exact same things. MORE >>